<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        29-325-01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2001
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        OCUMOL 0.5%
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        TIMOLOL MALEATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        0.5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        %
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Ophthalmic use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Eye drops
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Dropper Container
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        24.4
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="RIYADH PHARMA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            RIYADH PHARMA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 407]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            RIYADH PHARMA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            RIYADH PHARMA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        S01ED01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active ingredient timolol belongs to a group of medicines called beta-blockers</p><p>OCUMOL is used to treat raised pressure of eye (intraocular pressure) which occurs in various conditions including glaucoma and ocular hypertension</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take OCUMOL</strong></p><ul><li><strong>If you are </strong>allergic (hypersensitive) to timolol maleate or beta-blockers or to any other ingredient of this medicine (see section 6 for more details)</li><li><strong>If you have </strong>now or have had in past respiratory problems such as asthma, severe chronic obstructive bronchitis (severe lung disease which may cause wheeziness, difficulty in breathing and/or long-standing cough</li><li><strong>If you have </strong>a slow heartbeat, heart failure or disorders of heart rhythm (irregular heartbeats)</li></ul><p><strong>Take special care with OCUMOL </strong></p><p><strong>Before you use OCUMOL please tell your doctor if you have now or have had in the past</strong></p><ul><li>Coronary heart disease (symptoms can include chest pain or tightness, breathlessness or choking), heart failure, low blood pressure</li><li>Breathing problems, asthma or chronic obstructive pulmonary disease</li><li>Poor blood circulation disease (such as Raynaud&rsquo;s disease or Raynaud&rsquo;s syndrome)</li><li>Diabetes as OCUMOL may mask signs and symptoms of low blood sugar</li><li>Overactivity of the thyroid gland as OCUMOL may mask signs and symptoms</li><li>Tell your doctor before you have an operation that you are using OCUMOL as it may change effects of some medicines used during anaesthesia</li></ul><p><strong>Paediatric population</strong></p><p>OCUMOL eye drop solution should generally be used with caution in young patients. In newborns, infants and younger children OCUMOL should be used with extreme caution. If coughing, wheezing, abnormal breathing or abnormal pauses in breathing (apnoea) occur, the use of the medication should be stopped immediately. Contact your doctor as soon as possible. A portable apnoea monitor may also be helpful. OCUMOL has been studied in infants and children aged 12 days to 5 years, who have raised pressure in the eye(s) or have been diagnosed with glaucoma. For more information, talk to your doctor</p><p><strong>Using other medicines</strong></p><p>OCUMOL can affect or be affected by other medicines you are using, including other eye drops for the treatment of glaucoma. Tell your doctor if you are using or intend to use medicines to lower blood pressure, heart medicine or medicines to treat diabetes</p><p>:Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. In particular</p><ul><li>a calcium antagonist (e.g. verapamil or diltiazem) often used to treat high blood pressure, angina, or an abnormal heartbeat</li><li>digoxin, often used to treat heart failure or an abnormal heartbeat</li><li>medicines known as a catecholaminedepleting agents (e.g. rauwolfia alkaloids/ reserpine) used to treat high blood pressure</li><li>a pressor amine (e.g. adrenaline) used to treat severe allergic reaction</li><li>clonidine to treat high blood pressure</li><li>quinidine, a medicine used to treat heart conditions and some types of malaria</li><li>other beta-blockers (e.g. other preparations of timolol both oral and/or ocular), which belong to the same group of medicines</li><li>antidepressants known as fluoxetine and paroxetine</li></ul><p><strong>Pregnancy and breast-feeding</strong></p><p>Do not use OCUMOL if you are pregnant unless your doctor considers it necessary</p><p>Do not use OCUMOL if you are breast-feeding. OCUMOL may get into your milk.</p><p>Ask your doctor for advice before taking any medicine during breast-feeding.</p><p><strong>Driving and using machines</strong></p><p>No effects on ability to drive and use machines have been reported. However, do not drive or operate machines if you experience any visual disturbance after using the product. Wait until this clears before driving or using machines</p><p><strong>Important information about some of the ingredients of OCUMOL Eye Drops</strong></p><p>The eye drops contain benzalkonium chloride as preservative which may cause eye irritation. Avoid contact with soft contact lenses. Remove contact lenses before using the eye drops and wait at least 15 minutes before reinserting. The preservative is known to discolour soft contact lenses</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always use OCUMOL exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure. The usual starting dose is one drop of 0.25% eye drops into each affected eye(s) twice daily, approximately 12 hours apart. Your doctor will change your treatment as necessary. If you are using in combination with another eye drop medicine, wait 5-15 minutes before applying the second eye drop.</p><p><strong>Dose</strong></p><p><em>Paediatric population</em></p><p>A detailed medical examination should precede the use of OCUMOL. Your doctor will carefully evaluate the risks and benefits when considering treatment with OCUMOL. If the benefits outweigh the risks, it is recommended to use the lowest active agent concentration available once daily. With regard to &ldquo;the use in children&rdquo;, the 0.1% active agent concentration may be sufficient to control pressure within the eye. If the pressure is not sufficiently controlled with this dosage, a twice daily application at 12-hourly intervals may be necessary. Patients, especially newborn, should be closely observed for one to two hours after the first dose and careful monitoring for adverse events should be carried out until surgery is performed</p><p><strong>Instructions for use</strong></p><ul><li>First wash your hands</li><li>Avoid touching the eye (or any other surface) with the tip of the bottle</li><li>If you wear soft contact lenses, they should be removed before using the eye drops and wait at least 15 minutes before reinserting</li><li>Tilt your head back and look at the ceiling</li><li>Pull the lower eyelid gently downwards</li><li>Hold the bottle upside down above the eye and gently squeeze the bottle to release a drop into your eye</li><li>After using OCUMOL, press a finger into the corner of your eye, by the nose for 3 &ndash; 5 minutes. This helps to stop OCUMOL getting into the rest of the body</li><li>Repeat for the other eye if necessary</li><li>Replace and tighten the cap immediately after use</li></ul><p><u>Duration of treatment</u></p><p>For a transient treatment in the paediatric population. Be careful not to touch the tip of the bottle on your eye or on any other surface. Ocular solutions if handled wrongly can become contaminated by common bacteria and cause eye infections. If you do develop any other eye condition whilst using this product, see your doctor immediately. Keep using your medicine until your doctor tells you to stop</p><p><strong>If you use more OCUMOL than you should</strong></p><p>If you accidentally use too much, <strong>contact your doctor or go to the nearest hospital casualty department immediately</strong></p><p><u>Overdose</u></p><p>There is no experience of an overdosage with OCUMOL which is unlikely when given as eye drops. The signs of overdosage include slow heart rate, drop of blood pressure, breathing difficulties, and heart attack</p><p><strong>If you forget to use OCUMOL</strong></p><p>Apply the drops as soon as you remember. However, if it is almost time for your next dose, do not double your dose and carry on with the normal schedule dose</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, OCUMOL can cause side effects, although not everybody gets them. You can usually carry on taking the drops, unless the effects are serious. If you&rsquo;re worried, talk to a doctor or pharmacist. <strong>Do</strong> <strong>not stop using OCUMOL without speaking</strong> <strong>to your doctor</strong></p><p>If you experience a rare (these may affect between 1 in 1,000 and 1 in 10,000 patients) but serious allergic reaction (difficulty breathing, closing of the throat, swelling of the lips, tongue, or face or hives) to OCUMOL, stop using the medication and contact your doctor immediately</p><p>Like other medicines applied into eyes, OCUMOL is absorbed into the blood. This may cause similar side effects as seen with intraveneous&rsquo; and/or &lsquo;oral&rsquo; as applicable betablocking agents. Incidence of side effects after topical ophthalmic administration is lower than when medicines are, for example, taken by mouth or injected. Listed side effects include reactions seen within the class of beta-blockers when used for treating eye conditions:</p><ul><li>Generalized allergic reactions including swelling beneath the skin that can occur in areas such as the face and limbs, and can obstruct the airway which may cause difficulty swallowing or breathing, hives or itchy rash, localized and generalized rash, itchiness, severe sudden life-threatening allergic reaction</li><li>Low blood glucose level</li><li>Difficulty sleeping (insomnia), depression, nightmares, memory loss</li><li>Signs and symptoms of eye irritation (e.g. burning, stinging, itching, tearing, redness), inflammation of the eyelid, inflammation in the cornea, blurred vision and detachment of the layer below the retina that contains blood vessels following filtration surgery which may cause visual disturbances, decreased corneal sensitivity, dry eyes, corneal erosion damage to the front layer of the eyeball),drooping of the upper eyelid (making the eye stay half closed), conjunctivitis, double vision</li><li>Slow heart rate, chest pain, palpitations, oedema (fluid build up), changes in the rhythm or speed of the heartbeat, congestive heart failure (heart disease with shortness of breath and swelling of the feet and legs due to fluid build up), a type of heart rhythm disorder, heart block, heart failure, heart attack, low blood pressure,Raynaud&rsquo;s phenomenon, cold hands and feet</li><li>Constriction of the airways in the lungs (predominantly in patients with preexisting disease), difficulty breathing, nasal congestion, cough</li><li>Taste disturbances, loss of appetite, nausea, indigestion, diarrhoea, dry mouth, abdominal pain, vomiting</li><li>fainting, stroke, reduced blood supply to the brain, increased signs and symptoms of myasthenia gravis (weakness, droping eyelids, double vision, muscle disorder), dizziness, unusual sensations (like pins and needles), and headache</li><li>Hair loss, skin rash with white silvery coloured appearance (psoriasiform rash) or worsening of psoriasis, skin rash</li><li>Muscle pain not caused by exercise</li><li>Sexual dysfunction, decreased libido</li><li>Muscle weakness, tiredness</li><li>Depression, anxiety or psychiatric disturbances</li></ul><p><strong>If any of the side effects get serious, or if you notice any side effects not mentioned in this leaflet, please tell your doctor or pharmacist</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>- Keep out of reach and sight of children</p><p>- Store below 30&deg;C</p><p>- Keep in the original pack to protect from light</p><p>- Discard the bottle 28 days after opening, even if there is solution remaining</p><p>- Do not use OCUMOL after the expiry date which is stated on the bottle and on the carton the bottle is packed in</p><p>- Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active ingredient is Timolol, each 1 ml contains Timolol Maleate (USP) equivalent to Timolol 5 mg. This product also contains sodium dihydrogen phosphate dihydrate, disodium edetate, disodium hydrogen phosphate dodecahydrate, benzalkonium chloride (BP) 0.2 mg (as preservative) and water for injection</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                OCUMOL is a clear colourless, sterile solution
Each carton contains white plastic bottle with dropper contains 5 ml of OCUMOL solution

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><!--[if gte vml 1]><v:shapetype
 id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t"
 path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:354pt;
 height:132.75pt'>
 <v:imagedata src="file:///C:\Users\NEWUSE~1\AppData\Local\Temp\msohtmlclip1\01\clip_image001.png"
  o:title=""/>
</v:shape><![endif]--></p><p><strong>Marketing </strong><strong>Authorisation</strong><strong> Holder and Manufacturer</strong></p><p>Medical and Cosmetic Products Company Ltd. (Riyadh Pharma)</p><p>P.O.Box 442, Riyadh 11411</p><p>Fax: +966 11 265 0505</p><p>Email: contact@riyadhpharma.com</p><p><em>For any information about this medicinal product, please contact the local representative of marketing Authorisation holder:</em></p><p>Saudi Arabia</p><p>Marketing department</p><p>Riyadh</p><p>Tel: +966 11 265 0111</p><p>Email: marketing@riyadhpharma.com</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                12/2016
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>العنصر الفعال هو تيمولول ينتمي لمجموعة العقاقير تسمى حاصرات بيتا .</p><p>أوكيومول تستخدم لعلاج ارتفاع ضغط العين (ضغط العين الداخلي) والذي يحدث في حالات مختلفة بما في ذلك الجلوكوما وارتفاع ضغط الدم في العين.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>لا تستخدم أوكيومول</strong><strong> :</strong></p><ul><li><strong>إذا كنت</strong> تعاني من حساسية من التيمولول مالييت أو حاصرات بيتا أو أي مكون آخر من هذا الدواء (انظر القسم 6 لمزيد من التفاصيل)</li><li><strong>إذا كنت</strong> تعاني الآن أوكنت تعاني في الماضي من مشاكل في الجهاز التنفسي مثل الربو والتهاب الشعب الهوائية&nbsp; الانسدادي &nbsp;&nbsp;المزمن (داء الرئة الشديد الذي قد يؤدي إلى الأزيز وصعوبة في التنفس و / أو السعال طويل الأمد).</li><li><strong>إذا كان</strong> لديك بطء في ضربات القلب، فشل قلبي أو اضطرابات في ايقاع القلب (عدم انتظام ضربات القلب(</li></ul><p><strong>&nbsp;التحذيرات والاحتياطات</strong><br /><strong>&nbsp;قبل استخدام أوكيومول يرجى إخبار الطبيب إذا كان لديك الآن أو كان في الماضي:</strong></p><ul><li>مرض القلب التاجي (تشمل الأعراض ألم في الصدر أو ضيق، ضيق في التنفس أو الاختناق) ,فشل قلبي وانخفاض ضغط الدم.</li><li>مشاكل في التنفس، الربو أو مرض الانسداد الرئوي المزمن.</li><li>مرض ضعف الدورة الدموية (مثل مرض رينود أو متلازمة رينود).</li><li>السكري حيث أن أوكيومول قد تخفي علامات وأعراض انخفاض السكر في الدم.</li><li>النشاط الزائد للغدة الدرقية حيث أن أوكيومول قد تخفي العلامات والأعراض.</li></ul><p>أخبر طبيبك قبل إجراء أي عملية جراحية حيث أن أوكيومول قد تغير تأثير بعض الأدوية المستخدمة أثناء التخدير.</p><p><strong>الأطفال:</strong></p><p>محلول قطرة العين أوكيومول لابد أن تستخدم عامة بحذر في المرضى صغار السن. في حديثي الولادة والرضع والأطفال الصغار أوكيومول لابد أن تستخدم بحذر شديد. إذا حدث كحة، صفير، تنفس غير طبيعي أو توقف غير طبيعي للتنفس (انقطاع النفس)، لابد من التوقف فورا عن استخدام الدواء. اتصل بطبيبك في أقرب وقت ممكن. جهاز تنظيم انقطاع النفس المحمول قد يساعد أيضا.</p><p>تمت دراسة تأثير أوكيومول في الرضع والأطفال من سن 12 يوم إلى 5 سنوات الذين ارتفع لديهم ضغط العين/ العينين أو تم تشخيصهم بالجلوكوما. لمزيد من المعلومات، تحدث إلى طبيبك.</p><p><strong>الأدوية الأخرى و </strong><strong>أوكيومول</strong></p><p>أوكيومول يمكن أن تؤثر أو تتأثر بغيرها من الأدوية التي تستخدمها، بما في ذلك قطرات العين الأخرى التي تعالج الجلوكوما.</p><p>أخبر طبيبك إذا كنت تستخدم أو تنوي استخدام علاجات لخفض ضغط الدم، أدوية القلب أو أدوية علاج السكري</p><p>فضلا أخبر طبيبك أو الصيدلي إذا كنت تتناول أو تناولت مؤخرا أي أدوية أخرى، متضمنة الأدوية بدون وصفة وبالأخص:</p><ul><li>مضادات الكالسيوم (فيراباميل أو ديليتيازيم) التي تستخدم عادة لعلاج ارتفاع ضغط الدم، الذبحة أو عدم انتظام دقات القلب.</li><li>ديجوكسين، الذي يستخدم عادة لعلاج الفشل القلبي، عدم انتظام دقات القلب</li><li>الأدوية المعروفة بمستنفذات الكاتيكولامين ( قلويدات راوفولفية/ريزيربين ) وتستخدم لعلاج ارتفاع ضغط الدم</li><li>الأمين الرافع للضغط (أدرينالين ) المستخدم لعلاج رد الفعل التحسسي الشديد .</li><li>كلونيدين المستخدم لعلاج ارتفاع ضغط الدم.</li><li>كينيدين وهو علاج يستخدم في حالات القلب وبعض أنواع الملاريا.</li><li>حاصرات بيتا الأخرى (مستحضرات التيمولول الأخرى الفموية و/أو للعين)، التي تنتمي لنفس المجموعة الدوائية.</li><li>مضادات الاكتئاب المعروفة باسم فلوكستين و باروكسيتين.</li></ul><p><strong>الحمل والرضاعة الطبيعية</strong><br />لا تتناولي أوكيومول إذا كنت حامل مالم يعتبر طبيبك ذلك ضروري.</p><p>لا تتناولي أوكيومول إذا كنت ترضعين. أوكيومول قد يفرز مع اللبن.</p><p>اسألي طبيبك للنصيحة قبل تناول أي دواء أثناء الرضاعة الطبيعية.<br /><strong>استخدام الآلات والقيادة</strong><br />لا يوجد تأثير على القدرة على القيادة واستخدام الآلات تم الإبلاغ عنه.ومع ذلك لا تقم بالقيادة أو تشغيل الآلات إذا حدث لك اضطرابات في الرؤية بعد استخدام المنتج. انتظر حتى زوال المشكلة قبل القيادة أو استعمال الآلات.</p><p><strong>معلومات مهمة حول بعض المكونات الموجودة في قطرة العين أوكيومول:</strong></p><p>قطرة العين تحتوي على كلوريد البنزالكونيوم كمادة حافظة التي قد تسبب تهيج العين. تجنب استخدام العدسات اللاصقة اللينة. قم بإزالة العدسات اللاصقة قبل استخدام قطرة العين وانتظر 15 دقيقة قبل وضعها من جديد. المادة الحافظة معروف أنها تغير لون العدسات اللاصقة اللينة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>استخدم دائما أوكيومول تماما كما قد قال لك طبيبك. تحقق من طبيبك أو الصيدلي إذا لم تكن متأكدا.</p><p>جرعة البداية المعتادة هي نقطة واحدة من قطرة العين 0.25% في كل عين مصابة مرتين يوميا، تقريبا كل 12 ساعة. طبيبك سيغير علاجك إذا دعت الضرورة. إذا كنت تستخدم الدواء بالاشتراك مع قطرة عين أخرى، انتظر 5-15 دقيقة قبل استخدام قطرة العين الأخرى.</p><p><strong>الجرعة:</strong></p><p>الأطفال:</p><p>لابد أن يسبق استخدام أوكيومول فحص طبي مفصل. طبيبك سوف يحدد بحرص المخاطر والفوائد عند اختيار أوكيومول للعلاج. إذا كانت الفوائد تفوق المخاطر، فإنه يوصى باستخدام التركيز الأقل من المادة الفعالة المتوفرة مرة يوميا. فيما يتعلق بالاستخدام في الأطفال، جرعة 0.1% من تركيز المادة الفعالة ستكون كافية للتحكم في الضغط داخل العين. إذا كانت الجرعة غير كافية للتحكم في الضغط، قد يكون ضروريا الاستخدام مرتين يوميا كل 12 ساعة. المرضى خاصة حديثي الولادة لابد من ملاحظتهم عن قرب لمدة ساعة إلى ساعتين بعد الجرعة الأولى ولابد من المراقبة الدقيقة للأعراض الجانبية حتى إتمام الجراحة.</p><p><strong>تعليمات الاستخدام:</strong></p><ul><li>غسيل الأيدي أولا.</li><li>تجنب لمس العين (أو أي سطح) بواسطة طرف العبوة.</li><li>إذا كنت تستخدم عدسات لاصقة لينة، لابد من ازالتها قبل استخدام قطرة العين والانتظار 15 دقيقة قبل استخدامها.</li><li>أمل رأسك الى الوراء وانظر الى السقف</li><li>اسحب الجفن السفلي برفق إلى أسفل</li><li>أمسك العبوة رأسا على عقب فوق العين واضغط بلطف على العبوة لإنزال قطرة داخل العين</li><li>بعد استخدام أوكيومول، اضغط بأصبعك في زاوية العين، بجانب الأنف لمدة 3-5 دقائق. هذا يساعد على عدم دخول أوكيومول لبقية الجسم.</li><li>كرر في العين الأخرى عند الضرورة.</li></ul><p>أعد غطاء العبوة واحكم الغلق جيداً بعد الاستعمال مباشرة.</p><p><u>فترة العلاج:</u></p><p>لفترة مؤقتة في الأطفال.</p><p>كن حريصا على عدم لمس طرف العبوة للعين أو أي سطح اخر.</p><p>محاليل العين إذا ما تم تناولها بطريقة خاطئة قد تصبح ملوثة بالبكتيريا وتسبب عدوى للعين. راجع طبيبك فورا إذا حدث أي شيء أخر للعين أثناء استخدام هذا المنتج.</p><p>استمر في استخدام الدواء حتى يخبرك طبيبك التوقف.<br />&nbsp;</p><p><strong>إذا استخدمت أوكيومول أكثر مما يجب</strong></p><p>إذا استخدمت أكثر من اللازم عن غير قصد،<strong> اتصل بطبيبك أو اذهب على الفور لأقرب مستشفى قسم الطوارئ.</strong></p><p>الجرعة الزائدة:</p><p>ليس هناك تجربة للجرعة الزائدة مع أوكيومول وهو أمر غير مرجح مع قطرات العين. علامات الجرعة الزائدة تتضمن بطء معدل ضربات القلب، انخفاض ضغط الدم، صعوبة التنفس ونوبة قلبية.</p><p><strong>إذا نسيت استخدام أوكيومول</strong></p><p>استخدم القطرة بمجرد تذكرها. وإذا اقترب موعد الجرعة التالية، لا تضاعف الجرعة واستمر على موعد الجرعات العادية.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جميع الأدوية، يمكن أن يسبب أوكيومول آثارا جانبية على الرغم من أن ليس كل شخص تحدث له.</p><p>تستطيع دائما الاستمرار في استخدام القطرة، مالم تحدث أعراض جادة. إذا كنت قلقا، تحدث الى طبيبك أو الصيدلي.</p><p><strong>لا تتوقف عن استخدام أوكيومول دون استشارة طبيبك</strong>.</p><p>إذا حدث أعراض تحسسية نادرة (تؤثر في 1 من 1.000 و 1 من 10.000) ولكن جادة (صعوبة التنفس، غلق الحلق، تورم الشفاه، اللسان، الوجه أو بثور) بعد استخدام أوكيومول، توقف عن استخدام الدواء وتحدث مباشرة الى طبيبك.</p><p>مثل كل العلاجات التي تستخدم في العين، أوكيومول يمتص الي الدم. هذا قد يسبب أعراض جانبية مشابهة للتي تراها عند استخدام حاصرات بيتا عن طريق الحقن و/أو الفم. حدوث أثار جانبية بعد استخدام علاجات العين الموضعية أقل من العلاجات على سبيل المثال التي تستخدم عن طريق الفم أو الحقن.</p><p>تشمل الآثار الجانبية المذكورة ردود الفعل شوهدت ضمن فئة من حاصرات بيتا عند استخدامها لعلاج أمراض العيون:</p><ul><li>ردود الفعل التحسسية تتضمن تورم أسفل الجلد الذي قد يحدث في مناطق مثل الوجه والأطراف، ويمكن أن تعيق مجرى الهواء والتي قد تسبب صعوبة في البلع أو التنفس، بثور أو طفح جلدي وحكة، طفح جلدي محدود أو عام، حكة، ردود فعل تحسسية حادة مهددة للحياة.</li><li>انخفاض مستوى السكر في الدم.</li><li>صعوبة النوم (الأرق)، الاكتئاب، كوابيس ,فقدان ذاكرة.</li><li>علامات وأعراض تهيج العين (حرقان، لسع، حكة، دموع، احمرار) ,التهاب الجفن, التهاب القرنية, اضطراب الرؤية وانفصال طبقة تحت شبكية العين التي تحتوي على الأوعية الدموية بعد جراحة التصفية والتي قد تسبب اضطرابات بصرية، انخفاض حساسية القرنية، جفاف العين، تآكل القرنية (أضرار في الطبقة الأولى من مقلة العين)، تدلى الجفن العلوي (تجعل العين نصف مغلقة)، والتهاب الملتحمة، الرؤية المزدوجة.</li><li>&nbsp;بطء معدل ضربات القلب، خفقان، وذمة (تجمع سوائل)، تغير ايقاع أو سرعة دقات القلب. فشل القلب الاحتقاني (مرض قلبي مع مع ضيق في التنفس وتورم في القدمين والساقين نتيجة لتراكم السوائل)، نوع من اضطراب ايقاع القلب، إحصار القلب، فشل القلب، نوبة قلبية، انخفاض ضغط الدم، ظاهرة رينود، برودة اليدين والقدمين.</li><li>انقباض الشعب الهوائية في الرئتين (في الغالب في المرضى الذين يعانون من مرض موجود مسبقا)، صعوبة في التنفس، واحتقان الانف والسعال.</li><li>اضطرابات التذوق، فقدان الشهية، غثيان، عسر الهضم، الإسهال، جفاف الفم، آلام في البطن والقيء.</li><li>إغماء، السكتة الدماغية، انخفاض تدفق الدم إلى الدماغ، زيادة علامات وأعراض الوهن العضلي الوبيل (ضعف، تدلي الجفون، الرؤية المزدوجة، واضطراب العضلات)، الدوخة، الأحاسيس غير عادية (مثل وخز الدبابيس والإبر)، والصداع.</li><li>فقدان الشعر وطفح جلدي أبيض فضي اللون (صدافيه الطفح الجلدي) أو تفاقم مرض الصدفية والطفح الجلدي.</li><li>ألم العضلات غير الناجمة عن ممارسة الرياضة.</li><li>اختلال الوظائف الجنسية، وانخفاض الرغبة الجنسية.</li><li>ضعف العضلات، والتعب.</li><li>الاكتئاب، القلق أو اضطرابات نفسية.</li></ul><p>إذا أصبحت أي من الآثار الجانبية خطيرة، أو إذا لاحظت أي آثار جانبية غير المذكورة في هذه النشرة، يرجى إخبار الطبيب أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>- يحفظ بعيدا عن متناول أيدي ونظر الأطفال.</p><p>- يحفظ في درجة حرارة أقل من 30 درجة مئوية.</p><p>- يحفظ في العبوة الأصلية للحماية من الضوء.</p><p>- تخلص من العبوة بعد 28 يوما من الفتح، حتى وان كان جزء منها متبقي.</p><p>- لا تستخدم أوكيومول بعد تاريخ انتهاء الصلاحية المدون على العبوة وعلى الكرتون.</p><p>- لا تتخلص من أي أدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد مطلوبة. هذه التدابير تساعد في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المادة الفعالة هي تيمولول، حيث كل 1 مل يحتوي على تيمولول مالييت (دستور الأدوية الأمريكي) ما يعادل تيمولول 5 ملجم.</p><p>هذا المنتج يحتوي أيضا على صوديوم داي هيدروجين فوسفات داي هيدريت، داي صوديوم إيديدات، داي صوديوم هيدروجين فوسفات دوديكاهيدريت، كلوريد البنزالكونيوم (دستور الأدوية البريطاني) 0.2 ملجم (كمادة حافظة) وماء للحقن.</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>أوكيومول عبارة عن محلول صافي عديم اللون. كل كرتونه تحتوي على عبوة بلاستيكية بيضاء بقطارة تحتوي على 5 مل من محلول اوكيومول.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>اسم وعنوان مالك رخصة التسويق والمصنع</strong></p><p dir="RTL">شركة المنتجات الطبية والتجميلية المحدودة (الرياض فارما)</p><p dir="RTL">ص.ب. 442 الرياض 11411</p><p dir="RTL">فاكس: 966112650505+</p><p dir="RTL">البريد الإلكتروني: contact@riyadhpharma.com</p><p dir="RTL"><em>لأية معلومات عن هذا المنتج الطبي، يرجى الاتصال على صاحب الترخيص والتسويق:</em></p><p dir="RTL">المملكة العربية السعودية</p><p dir="RTL">قسم التسويق</p><p dir="RTL">الرياض</p><p dir="RTL">تلفون: 966112650111+</p><p dir="RTL">البريد الإلكتروني: marketing@riyadhpharma.com</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            12/2016
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Ocumol Eye Drops 0.5%

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Active Ingredient

Timolol maleate equivalent to 0.5% w/v of Timolol

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Eye drops, solution

Clear, colourless solution free from particles

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;Reduction of elevated intraocular pressure in conditions such as</p><ul><li>Ocular hypertension</li><li>Chronic open-angle glaucoma (including aphakic patients)</li><li>Some cases of secondary glaucom</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adults and children over 12 years: recommended therapy is one drop of Ocumol 0.5% Eye Drops in the affected eye(s) twice a day</p><p>Elderly: Dosage need not be modified for the elderly as there has been wide experience with the use of Ocumol Eye Drops 0.5% in elderly patients</p><p>When using nasolacrimal occlusion or closing the eyelids for 2 minutes, the systemic absorption is reduced. This may result in a decrease in systemic side effects and an increase in local activity</p><p>Intraocular pressure should be reassessed approximately four weeks after starting treatment because response to Ocumol Eye Drops 0.5% may take a few weeks to stabilise. Provided that intraocular pressure is maintained at satisfactory levels, many patients can then be placed on once daily therapy</p><p>If necessary, concomitant treatment with miotics, epinephrine and/or carbonic anhydrase inhibitors can be instituted. In order to prevent the active substance(s) from being washed out when additional ophthalmic medication is used, an interval of at least 10 minutes between each application is recommended. The use of two topical beta-adrenergic agents is not recommended</p><p>Transfer from other topical beta-blocking agents: Discontinue use after a full day of therapy and start treatment with Ocumol Eye Drops 0.5% the next day, with one drop in each affected eye twice daily</p><p>Transfer from a single antiglaucoma agent other than a topical beta-blocking agent: Continue the agent and add one drop of Ocumol Eye Drops 0.5% in each affected eye twice daily. On the following day, discontinue the previous agent completely, and continue with Ocumol Eye Drops 0.5%</p><p>Patients should be instructed to remove soft contact lenses before using Ocumol</p><p><em>Paediatric Population</em></p><p>Due to limited data, Ocumol could only be recommended for use in Primary congenital and primary juvenile glaucoma for a transitional period while decision is made on a surgical approach and in case of failed surgery while awaiting further options</p><p><strong><em>Posology</em></strong></p><p>Clinicians should strongly evaluate the risks and benefits when considering medical therapy with Ocumol in paediatric patients. A detailed paediatric history and examination to determine the presence of systemic abnormalities should precede the use of Ocumol</p><p>No specific dosage recommendation can be given as there is only limited clinical data (see also section 5.1). However, if benefit outweighs the risk, it is recommended to use the lowest active agent concentration available once daily. If IOP could not be sufficiently controlled, a careful up titration to a maximum of two drops daily per affected eye has to be considered. If applied twice daily, an interval of 12 hours should be preferred</p><p>Furthermore the patients, especially neonates, should be strongly observed after the first dose for one to two hours in the office and closely monitored for ocular and systemic side effects until surgery is performed. With regard to paediatric use, the 0.1% active agent concentration might already be sufficient</p><p><strong><em>Method of administration</em></strong></p><p>To limit potential adverse effects only one drop should be instilled per dosing time. Systemic absorption of topically administered &beta;-blockers can be reduced by nasolacrimal occlusion and by keeping the eyes closed as long as possible (e.g. for 3 - 5 minutes) after instillation of drops. See also section 4.4, 5.2</p><p><strong><em>Duration of treatment</em></strong></p><p>For a transient treatment in the paediatric population (see also section 4.2 &ldquo;Paediatric Population&rdquo;)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                  Ocumol Eye Drops 0.5% is contraindicated in patients with:
•	Cardiogenic shock;
•	Overt cardiac failure;
•	Second and third degree AV block not controlled with pace-maker;
•	Sinus bradycardia, sick sinus syndrome sino-atrial block;
•	Reactive airway disease including bronchial asthma or a history of bronchial asthma;
•	Presence or history of severe chronic obstructive pulmonary disease;
•	Severe peripheral circulatory disturbances (Raynaud disease);
•	Hypersensitivity to the active substance, any of the excipients or other beta-blocking agents

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Like other topically applied ophthalmic drugs, Ocumol Eye Drops is absorbed systemically. Due to beta-adrenergic component, timolol, the same types of cardiovascular, pulmonary and other adverse reactions seen with systemic beta-adrenergic blocking agents may occur. Incidence of systemic ADRs after topical ophthalmic administration is lower than for systemic administration. To reduce the systemic absorption, see 4.2</p><p><em>Cardiac disorders</em></p><p>In patients with cardiovascular diseases (e.g. coronary heart disease, Prinzmetal&#39;s angina and cardiac failure) and hypotension therapy with beta-blockers should be critically assessed and the therapy with other active substances should be considered. Patients with cardiovascular diseases should be watched for signs of deterioration of these diseases and of adverse reactions. Due to its negative effect on conduction time, beta-blockers should only be given with caution to patients with first degree heart block</p><p><em>Vascular disorders</em></p><p>Patients with severe peripheral circulatory disturbance/disorders (i.e. severe forms of Raynaud&#39;s disease or Raynaud&#39;s syndrome) should be treated with caution</p><p><em>Respiratory disorders</em></p><p>Respiratory reactions, including death due to bronchospasm in patients with asthma have been reported following administration of some ophthalmic beta-blockers</p><p>Ocumol Eye Drops should be used with caution, in patients with mild/moderate chronic obstructive pulmonary disease (COPD) and only if the potential benefit outweighs the potential risk</p><p><em>Hypoglycaemia/diabetes</em></p><p>Beta-blockers should be administered with caution in patients subject to spontaneous hypoglycaemia or to patients with labile diabetes, as beta-blockers may mask the signs and symptoms of acute hypoglycaemia. Beta-blockers may also mask the signs of hyperthyroidism</p><p><em>Corneal diseases</em></p><p>Ophthalmic &beta;-blockers may induce dryness of eyes. Patients with corneal diseases should be treated with caution. Other beta-blocking agents</p><p>The effect on intra-ocular pressure or the known effects of systemic beta-blockade may be potentiated when timolol eye drops is given to the patients already receiving a systemic beta-blocking agent. The response of these patients should be closely observed. The use of two topical beta-adrenergic blocking agents is not recommended (see section 4.5)</p><p><em>Anaphylactic reactions</em></p><p>While taking beta-blockers, patients with history of atopy or a history of severe anaphylactic reaction to a variety of allergens may be more reactive to repeated challenge with such allergens and unresponsive to the usual dose of adrenaline used to treat anaphylactic reactions</p><p><em>Choroidal detachment</em></p><p>Choroidal detachment has been reported with administration of aqueous suppressant therapy (e.g. timolol, acetazolamide) after filtration procedures</p><p><em>Surgical anaesthesia</em></p><p>&beta;-blocking ophthalmological preparations may block systemic &beta;-agonist effects e.g. of adrenaline. The anaesthesiologist should be informed when the patient is receiving Ocumol</p><p>This formulation of Ocumol Eye Drops contains benzalkonium chloride as a preservative which may be deposited in soft contact lenses. Hence, Ocumol Eye Drops should not be used while wearing these lenses. The lenses should be removed before instillation of the drops and not reinserted earlier than 15 minutes after use</p><p>When Ocumol Eye Drops is used to reduce intraocular pressure in angle-closure glaucoma, it should be used with a miotic and not alone</p><p>A reduction in ocular hypotensive response has been reported in some patients following prolonged therapy with Timolol maleate eye drops</p><p>Muscle weakness: Beta-adrenergic blockade has been reported to potentiate muscle weakness consistent with certain myasthenic symptoms (e.g. diplopia, ptosis, and generalised weakness). Ocumol Eye Drops have been reported rarely to increase muscle weakness in some patients with myasthenia gravis or myasthenic symptoms.</p><p>Patients should be instructed to avoid allowing the tip of the dispensing container to contact the eye or surrounding structures</p><p>Patients should also be instructed that ocular solutions, if handled improperly can become contaminated by common bacteria known to cause ocular infections. Serious damage to the eye and subsequent loss of vision may result from using contaminated solutions</p><p>Patients should also be advised that if they develop any intercurrent ocular condition (e.g. trauma, ocular surgery or infection), they should immediately seek their physician&#39;s advice concerning the continued use of present multi-dose container</p><p>There have been reports of bacterial keratitis associated with the use of topical ophthalmic products</p><p><u>Paediatric Population</u></p><p>Ocumol solutions should generally be used cautiously in young glaucoma patients (see also section 5.2). It is important to notify the parents of potential side effects so they can immediately discontinue the drug therapy. Signs to look for are for example coughing and wheezing. Because of the possibility of apnoea and Cheyne-Stokes breathing, the drug should be used with extreme caution in neonates, infants and younger children. A portable apnoea monitor may also be helpful for neonates on Ocumol</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No specific drug interaction studies have been performed with timolol</p><p>There is a potential for additive effects resulting in hypotension and/or marked bradycardia when ophthalmic beta-blockers solution is administered concomitantly with oral calcium channel blockers, beta-adrenergic blocking agents, antiarrhythmics (including amiodarone), digitalis glycosides, parasympathomimetics, guanethidine</p><p>Potentiated systemic beta-blockade (e.g., decreased heart rate, depression) has been reported during combined treatment with CYP2D6 inhibitors (e.g. quinidine, fluoxetine, paroxetine) and timolol</p><p>Mydriasis resulting from concomitant use of ophthalmic beta-blockers and adrenaline (epinephrine) has been reported occasionally</p><p>Clonidine: increased risk of &quot;rebound hypertension&quot; on discontinuation of clonidine</p><p>Anaesthetic drugs: increased risk of myocardial depression and hypotension due to blockage of cardiac response to reflex sympathetic stimuli</p><p>Cimetidine, hydralazine, phenothiazines and alcohol: may increase plasma level of timolol</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pregnancy</strong></p><p>There are no adequate data for the use of timolol in pregnant women. Ocumol should not be used during pregnancy unless clearly necessary</p><p>To reduce the systemic absorption, see 4.2</p><p>Epidemiological studies have not revealed malformative effects but show a risk for intra uterine growth retardation when beta-blockers are administered by the oral route. In addition, signs and symptoms of beta-blockade (e.g. bradycardia, hypotension, respiratory distress and hypoglycaemia) have been observed in the neonate when beta-blockers have been administered until delivery. If Ocumol Eye Drops is administered until delivery, the neonate should be carefully monitored during the first days of life. Ocumol Eye Drops 0.25% has not</p><p><strong>Lactation</strong></p><p>Beta-blockers are excreted in breast milk. However, at therapeutic doses of timolol in eye drops it is not likely that sufficient amounts would be present in breast milk to produce clinical symptoms of beta-blockade in the infant. To reduce the systemic absorption, see 4.2. Ocumol</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are currently no data available on the effects of Ocumol Eye Drops 0.5% on the ability to drive or use machinery. It has to be taken into account that dizziness, fatigue, transient ocular irritation, blurred vision and lacrimation may occur occasionally</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Like other topically applied ophthalmic drugs, timolol is absorbed into the systemic circulation. This may cause similar undesirable effects as seen with systemic beta-blocking agents. Incidence of systemic ADRs after topical ophthalmic administration is lower than for systemic administration. Listed adverse reactions include reactions seen within the class of ophthalmic beta-blockers</p><p><em>Immune system disorders</em></p><p>Systemic allergic reactions including angioedema, urticaria, localized and generalized rash, pruritus, anaphylactic reaction</p><p><em>Metabolism and nutrition disorders</em></p><p>Hypoglycaemia</p><p><em>Psychiatric disorders</em></p><p>Insomnia, depression, nightmares, memory loss</p><p><em>Nervous system disorders</em></p><p>Syncope, cerebrovascular accident, cerebral ischemia, increases in signs and symptoms of myasthenia gravis, dizziness, paraesthesia, and headache</p><p><em>Eye disorders</em></p><p>Signs and symptoms of ocular irritation (e.g. burning, stinging, itching, tearing, redness), blepharitis, keratitis, blurred vision and choroidal detachment following filtration surgery (see 4.4 Special warnings and special precautions for use), conjunctivitis, decreased corneal sensitivity, dry eyes, corneal erosion ptosis, diplopia</p><p><em>Cardiac disorders</em></p><p>Bradycardia, chest pain, palpitations, oedema, arrhythmia, congestive heart failure, atrioventricular block, cardiac arrest, cardiac failure</p><p><em>Vascular disorders</em></p><p>Hypotension, Raynaud&#39;s phenomenon, cold hands and feet, intermittent claudication</p><p><em>Respiratory, thoracic, and mediastinal disorders</em></p><p>Bronchospasm (predominantly in patients with pre-existing bronchospastic disease), dyspnoea, cough, respiratory failure, nasal congestion</p><p><em>Gastrointestinal disorders</em></p><p>Dysgeusia, nausea, dyspepsia, diarrhoea, dry mouth, abdominal pain, vomiting</p><p><em>Skin and subcutaneous tissue disorders</em></p><p>Alopecia, psoriasiform rash or exacerbation of psoriasis, skin rash</p><p><em>Musculoskeletal and connective tissue disorders</em></p><p>Myalgia</p><p><em>Reproductive system and breast disorders</em></p><p>Sexual dysfunction, decreased libido</p><p><em>General disorders and administration site conditions</em></p><p>Asthenia/fatigue</p><p><u>The following adverse events have been reported but a causal relationship to therapy with timolol eye drops has not been established</u></p><p><em>Metabolism &amp; nutrition disorders:</em>&nbsp;anorexia</p><p><em>Psychiatric disorders</em>: behavioural disorders including confusion, hallucination, anxiety, disorientation, nervousness, somnolence, psychic disturbances</p><p><em>Eye disorders:</em>&nbsp;aphakic cystoids macular oedema</p><p><em>Cardiac disorders:</em>&nbsp;angina pectoris aggravated</p><p><em>Vascular disorders:&nbsp;</em>hypertension, pulmonary oedema</p><p><em>Gastrointestinal disorders:&nbsp;</em>retroperitoneal fibrosis</p><p><em>Skin and subcutaneous tissue disorders:&nbsp;</em>pemphigoid</p><p><em>Reproductive system and breast disorders:&nbsp;</em>impotence</p><p><u>The following additional adverse events have been reported with oral timolol maleate and may be considered as potential effects of ophthalmic timolol maleate:</u></p><p><em>Blood &amp; lymphatic system disorders:</em>&nbsp;purpura non-thrombocytopenic</p><p><em>Metabolism &amp; nutrition disorders:</em>&nbsp;weight loss, hyperglycaemia</p><p><em>Nervous system disorders:&nbsp;</em>vertigo</p><p><em>Psychiatric disorders</em>: concentration impaired</p><p><em>Ear disorders:</em>&nbsp;tinnitus</p><p><em>Vascular disorders:&nbsp;</em>arterial insufficiency, vasodilation</p><p><em>Respiratory, thoracic, and mediastinal disorders:&nbsp;</em>rales, bronchial obstruction</p><p><em>Hepatobiliary disorders:&nbsp;</em>hepatomegaly</p><p><em>Skin and subcutaneous tissue disorders:&nbsp;</em>skin irritation, pigmentation abnormal, sweating</p><p><em>Musculoskeletal &amp; connective tissue disorders:&nbsp;</em>pain in extremity, arthralgia</p><p><em>Renal and urinary disorders:&nbsp;</em>dysuria</p><p><em>General disorders and administration site conditions:&nbsp;</em>exercise tolerance decreased</p><p><u>In addition, the following additional adverse events have been reported with other beta-adrenergic blocking agents and may be considered as potential effects of ophthalmic timolol maleate</u></p><p><em>Immune system disorders:</em>&nbsp;fever combined with general muscle aches, throat sore, laryngospasm and respiratory distress</p><p><em>Blood &amp; lymphatic system disorders:</em>&nbsp;agranulocytosis, thrombocytopenic purpura</p><p><em>Psychiatric disorders</em>: catatonia, an acute reversible syndrome (disorientation, memory loss, emotional lability, depressed level of consciousness, performance status decreased)</p><p><em>Gastrointestinal disorders:&nbsp;</em>mesenteric artery thrombosis, colitis ischaemic</p><p><em>Reproductive system and breast disorders:&nbsp;</em>Peyronie&#39;s disease</p><p>There have been reports of a syndrome comprising psoriasiform skin rash, conjunctivitis, otitis and sclerosing serositis attributed to the beta-adrenergic receptor blocking agent, practolol. This syndrome has also been reported with timolol maleate</p><p><strong><u>Reporting of suspected adverse reactions</u></strong></p><p>- National Pharmacovigilance and Drug Safety Center (NPC)</p><ul><li>Fax: +966-11-205-7662</li><li>To contact national Pharmacovigilance management: +966-11-2038222 ext.: 2353 &ndash; 2356 &ndash; 2317 &ndash; 2354 &ndash; 2334 &ndash; 2340</li><li>Toll-free: 8002490000</li><li>E-mail: npc.drug@sfda.gov.sa</li><li>Website: www.sfda.gov.sa/npc</li></ul><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No specific data are available. Overdosage is unlikely to occur as one 5ml bottle of Ocumol Eye Drops 0.5% contains 25 mgs of Timolol maleate compared with the usual adult oral dose of 20-60 mgs per day. However, in the rare event that overdosage occurs the most common signs and symptoms to be expected following overdosage with a beta-adrenergic receptor blocking agent are symptomatic bradycardia, hypotension, bronchospasm, and acute cardiac failure. If overdosage occurs, the following measures should be considered</p><ul><li>1. Gastric lavage, if ingested. Studies have shown that timolol cannot be easily removed by hemodialysis</li><li>2. Symptomatic bradycardia: Atropine sulphate, 0.25 to 2mg intravenously, should be used to induce vagal blockade. If bradycardia persists, intravenous isoprenaline hydrochloride should be administered cautiously. In refractory cases, the use of a cardiac pacemaker may be considered</li><li>3. Hypotension: A sympathomimetic pressor agent such as dopamine, dobutamine or noradrenaline should be used. In refractory cases, the use of glucagon has been reported to be useful</li><li>4. Bronchopasm: Isoprenaline hydrochloride should be used. Additional therapy with aminophylline may be considered</li><li>5. Acute cardiac failure: conventional therapy with digitalis, diuretics and oxygen should be instituted immediately. In refractory cases, the use of intravenous aminophylline is suggested. This may be followed, if necessary, by glucagon which has been reported to be useful</li><li>6. Heart block (second or third degree): Isoprenaline hydrochloride or a pacemaker should be used</li></ul>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Timolol is a non-selective &beta;-adrenergic blocker, which does not possess significant intrinsic sympathomimetic or local anaesthetic (membrane-stabilising) activity. When applied topically in the eye, it reduces both elevated and normal intraocular pressure by inhibiting the production of aqueous humour</p><p>Unlike miotics, Timolol reduces intraocular pressure with little or no effect on pupil size or accommodation</p><p>The onset of reduction in intraocular pressure following ocular administration of timolol can be detected within 30 minutes after a single dose The maximum effect usually occurs in one to three hours and significant lowering of intraocular pressure can be maintained for as long as 24 hours following a single dose</p><p>If systemically absorbed, as is possible, Timolol maleate is capable of producing beta-blockade elsewhere in the body with consequent systemic effects (increased airway resistance, bradycardia, hypotension etc.)</p><p><u>Paediatric Population</u></p><p>There is only very limited data available on the use of Timolol (0.25%, 0.5% twice daily one drop) in the paediatric population for a treatment period up to 12 weeks. One small, double blinded, randomized, published clinical study conducted on 105 children (n=71 on Timolol) aged 12 days - 5 years show to some extent evidence, that Timolol in the indication&nbsp;<em>primary congenital</em>&nbsp;and&nbsp;<em>primary juvenile glaucoma</em>&nbsp;is effective in short term treatment</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Topical instillation of 50&mu;l of a 0.5% solution of timolol to the rabbit eye resulted in rapid appearance of timolol in the aqueous humour and to a much lesser degree in the plasma. The concentration in the aqueous humour (mean of 2.47&mu;g/ml) peaked 30 minutes after instillation. The plasma concentration (0.188 &mu;g/ml) also peaked at this time</p><p>Following topical instillation in humans, the timolol concentration in aqueous humour was 8-100 ng/ml within the first hour while the mean plasma concentration was approximately 1 ng/ml within the first few hours (compared with plasma concentrations of 5-50 ng/ml seen with therapeutic doses of oral timolol)</p><p><u>Paediatric Population</u></p><p>As already confirmed by adult data, 80% of each eye drop passes through the nasolacrimal system where it may be rapidly absorbed into the systemic circulation via the nasal mucosa, conjunctiva, nasolacrimal duct, oropharynx and gut, or the skin from tear overflow. Due to the fact that the blood volume in children is smaller than that in adults a higher circulation concentration has to be taken into account. In addition, neonates have immature metabolic enzyme pathways and it may result in an increase in elimination half-life and potentiating adverse events. Limited data show that plasma timolol levels in children after 0.25% greatly exceed those in adults after 0.5%, especially in infants and are presumed to increase the risk of side effects such as bronchospasm and bradycardia</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Acute Toxicity Studies:</strong>&nbsp;Data have been reported in a number of animal species. Oral LD<sub>50</sub>&nbsp;in the mouse and rat are 1137 mg/kg and 1028 mg/kg respectively. Subcutaneous LD<sub>50</sub>&nbsp;in the mouse and rat are 300 mg/kg and 381 mg/kg respectively</p><p><strong>Chronic Toxicity Studies:</strong>&nbsp;No adverse ocular effects were observed with ophthalmic topical administration of timolol in rabbits and dogs in studies lasting one and two years respectively. In studies with oral administration in high doses in dogs and rats, bradycardia and weight increase in the heart, kidneys and liver were observed adverse effects</p><p><strong>Carcinogenicity:</strong>&nbsp;In a life-time study in mice, timolol increased the incidence of benign and malignant pulmonary tumors, benign uterine polyps and mammary adenocarcinomas in female mice when administered orally at doses of 500mg/kg per day, but not at 5 or 50 mg/kg per day. In a 2 year study in rats, oral timolol increased the incidence of adrenal pheochromocytomas in male rats at 300 mg/kg per day but not at 25 or 100 mg/kg per day</p><p><strong>(Mutagenicity:</strong>&nbsp;Timolol was not shown to be mutagenic when tested in vivo (mouse) in the micronucleus test and cytogenetic assay (at doses up to 800 mg/kg) and in vitro in a neoplastic cell transformation assay (up to 0.1 mg per ml</p><p><strong>Reproduction and fertility:</strong>&nbsp;Reproduction and fertility studies in rats have not shown that timolol causes any adverse effects on male or female fertility when administered orally at doses of up to 125 times the maximum recommended human oral dose of 30mg. Studies in rats have shown that timolol at doses of up to 50mg/kg/day (50 times the maximum recommended human oral dose) caused delayed foetal ossification; however there were no adverse effects on post-natal development of offspring. Teratogenic studies in mice and rabbits have not shown that timolol at doses of up to 50 mg/kg/day causes foetal malformations. In mice, timolol at doses of 1000 mg/kg/day (1000 times the maximum recommended human oral dose) was maternotoxic and resulted in an increased incidence of foetal resorptions</p><p>In rabbits, timolol at 100 mg/kg/day (100 times the maximum recommended human oral dose) increased incidence of foetal resorptions but not maternotoxicity</p><p>Timolol maleate 0.5% eye drops have not been adequately studied in human pregnancy. Although timolol eye drops may be absorbed systemically, daily treatment with Ocumol Eye Drops 0.5% (1 drop, twice daily in both eyes) will not exceed 0.4mgs timolol compared with the oral therapeutic dose of 20-60 mgs/day. However as a precautionary measure, it is recommended that timolol should not be used in pregnancy, unless the potential benefit to the pregnant woman exceeds the potential risk to the foetus</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>%Ocumol 0.5</strong></p><p>Benzalkonium chloride</p><p>Disodium edetate</p><p>Sodium chloride</p><p>Sodium dihydrogen phosphate dihydrate</p><p>Disodium hydrogen phosphate dodecahydrate</p><p>Water for injection</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Benzalkonium chloride may be deposited in soft contact lenses. These lenses should therefore be removed before instillation of the eye drops and not reinserted earlier than 15 minutes after use</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Unopened :36 Months
Opened : 28 days

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C</p><p>Keep in the original pack to protect from light</p><p>Once the pack has been opened, the contents should be used within 28 days</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>5ml plastic bottle with white plastic cap and pilfer proof</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Patients should be instructed to avoid allowing the tip of the dispensing container to contact the eye or surrounding structures</p><p>Patients should also be instructed that ocular solutions, if handled improperly, can become contaminated by common bacteria known to cause ocular infections. Serious damage to the eye and subsequent loss of vision may result from using contaminated solutions</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Medical and Cosmetic Products Company Ltd. (Riyadh Pharma)
P.O. Box 442, Riyadh 11411
Fax: +966 11 265 0505
Email: contact@riyadhpharma.com
For any information about this medicinal product, please contact the local representative of marketing authorisation holder:
Saudi Arabia
Marketing department
Riyadh
Tel: +966 11 265 0111
Email: marketing@riyadhpharma.com 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                05/2017
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>